Erelzi and Appetite disorder - a phase IV clinical study of FDA data

Summary:

Appetite disorder is reported as a side effect among people who take Erelzi (etanercept-szzs), especially for people who are female, 60+ old, also take Premarin, and have Arthritis.

The phase IV clinical study analyzes which people have Appetite disorder when taking Erelzi. It is created by eHealthMe based on reports of 11,624 people who have side effects when taking Erelzi from the FDA, and is updated regularly.

What is Erelzi?

Erelzi has active ingredients of etanercept-szzs. eHealthMe is studying from 11,625 Erelzi users. Check the latest studies of Erelzi.

What is Appetite disorder?

Appetite disorder (abnormal eating habits) is found to be associated with 715 drugs and 706 conditions by eHealthMe. Check the latest studies of Appetite disorder.

On Jul, 09, 2026

11,624 people reported to have side effects when taking Erelzi.
Among them, 33 people (0.28%) have Appetite disorder.

Among these 33 people:

What is the gender of people who have Appetite disorder when taking Erelzi? *

female: 100 %
male: 0.0 %

What is the age of people who have Appetite disorder when taking Erelzi? *

What are other drugs people take besides Erelzi? *

What are other side effects people have besides Appetite disorder? *

Joint Pain: 32 people, 96.97%
Chest Pain: 32 people, 96.97%
Pain: 31 people, 93.94%
Nausea (feeling of having an urge to vomit): 30 people, 90.91%
Enthesopathy (disorder of entheses (bone attachments)): 30 people, 90.91%
Hyperhidrosis (abnormally increased sweating): 30 people, 90.91%
Weight Decreased: 30 people, 90.91%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 30 people, 90.91%
Malaise (a feeling of general discomfort or uneasiness): 30 people, 90.91%
Defaecation Urgency (a sudden compelling urge to defecate): 30 people, 90.91%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 30 people, 90.91%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 29 people, 87.88%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 14 people, 42.42%
Thyroid Diseases: 13 people, 39.39%
Bone Disorder: 13 people, 39.39%
Migraine (headache): 2 people, 6.06%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.03%
Pain: 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Erelzi and have Appetite disorder?

- Check whether Appetite disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erelzi:

Erelzi (11,625 reports)

Browse all side effects of Erelzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite disorder:

Appetite disorder (715 drugs)

Browse all the conditions that are associated with Appetite disorder:

Appetite disorder (706 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept-szzs (the active ingredients of Erelzi) and Erelzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.